The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Understanding the rate of erectile dysfunction (ED) and testosterone deficiency is crucial in developing screening and treatment strategies.

Its growth is driven by a rising awareness of hypogonadism. The global testosterone replacement therapy (TRT) market is ...